Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension

A. Goudie, P. Hopkinson, B. Lipworth, A. Struthers (Dundee, United Kingdom)

Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Session: Pulmonary circulation: clinical treatment
Session type: Thematic Poster Session
Number: 4071
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Goudie, P. Hopkinson, B. Lipworth, A. Struthers (Dundee, United Kingdom). Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension. Eur Respir J 2013; 42: Suppl. 57, 4071

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison pulmonary rehabilitation efficiency in COPD patients between with and without pulmonary hypertension
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014

Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Association between arterial stiffness and acute exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Pulmonary hypertension in COPD
Source: Eur Respir J 2008; 32: 1371-1385
Year: 2008



Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003

Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005

The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension
Source: International Congress 2014 – Comorbidities
Year: 2014

Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015

Cardiopulmonary exercise test (CPET) may show initial right cardiac dysfunction in patients with moderate-severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Best abstracts in physical activity and exercise testing
Year: 2014

Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014


Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Relevance of hemoglobin A1c and acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Pulmonary hypertension in patients with COPD
Source: Eur Respir Mon 2012; 57: 138-147
Year: 2012